FdaApplication
ANDA 202294
Identifiers
- fda_app_no: ANDA202294
Properties
| Property | Value |
|---|---|
| applicant_name | PH HEALTH LTD |
| application_type | ANDA |
| approval_date | 2017-04-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 30MG | CAPSULE, DELAYED RELEASE;ORAL |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 60MG | CAPSULE, DELAYED RELEASE;ORAL |
2 products